1.646.889.1200|info@lifescipublicrelations.com

DalCor Keeps Faith In CETP Biomarker, Despite No Dice For Merck’s REVEAL Genetic Analysis

//DalCor Keeps Faith In CETP Biomarker, Despite No Dice For Merck’s REVEAL Genetic Analysis

DalCor Keeps Faith In CETP Biomarker, Despite No Dice For Merck’s REVEAL Genetic Analysis

Hopes for a precision approach for the vast cardiovascular disease population live on – past failed studies of HDL-raising drugs and lack of evidence for genetic typing in Merck’s latest analysis of anacetrapib in REVEAL.

By | 2019-03-22T14:55:51-04:00 March 20th, 2019|News|Comments Off on DalCor Keeps Faith In CETP Biomarker, Despite No Dice For Merck’s REVEAL Genetic Analysis

About the Author:

Related Posts

LifeSci Public Relations

LifeSci Public Relations LLC is a corporate communications and public relations firm helping clients engage their corporate audiences and achieve their business objectives via a broad array of traditional, social and digital media tools.